Literature DB >> 34186102

Neurotoxicity of methamphetamine: Main effects and mechanisms.

Subramaniam Jayanthi1, Atul P Daiwile1, Jean Lud Cadet2.   

Abstract

Methamphetamine (METH) is an illicit psychostimulant that is abused throughout the world. METH addiction is also a major public health concern and the abuse of large doses of the drug is often associated with serious neuropsychiatric consequences that may include agitation, anxiety, hallucinations, paranoia, and psychosis. Some human methamphetamine users can also suffer from attention, memory, and executive deficits. METH-associated neurological and psychiatric complications might be related, in part, to METH-induced neurotoxic effects. Those include altered dopaminergic and serotonergic functions, neuronal apoptosis, astrocytosis, and microgliosis. Here we have endeavored to discuss some of the main effects of the drug and have presented the evidence supporting certain of the molecular and cellular bases of METH neurotoxicity. The accumulated evidence suggests the involvement of transcription factors, activation of dealth pathways that emanate from mitochondria and endoplasmic reticulum (ER), and a role for neuroinflammatory mechanisms. Understanding the molecular processes involved in METH induced neurotoxicity should help in developing better therapeutic approaches that might also serve to attenuate or block the biological consequences of use of large doses of the drug by some humans who meet criteria for METH use disorder. Published by Elsevier Inc.

Entities:  

Keywords:  Autophagy; Bcl2; Cell death; ER stress; Mitochondrial cascade; Neuroinflammation; Transcription factors

Mesh:

Substances:

Year:  2021        PMID: 34186102      PMCID: PMC8338805          DOI: 10.1016/j.expneurol.2021.113795

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.620


  213 in total

1.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

Review 2.  Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.

Authors:  Hwan-Ching Tai; Erin M Schuman
Journal:  Nat Rev Neurosci       Date:  2008-11       Impact factor: 34.870

Review 3.  Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.

Authors:  William J Panenka; Ric M Procyshyn; Tania Lecomte; G William MacEwan; Sean W Flynn; William G Honer; Alasdair M Barr
Journal:  Drug Alcohol Depend       Date:  2012-12-27       Impact factor: 4.492

Review 4.  Role of microglia in methamphetamine-induced neurotoxicity.

Authors:  Enquan Xu; Jianuo Liu; Han Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

5.  Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons.

Authors:  Bing Li; Rui Chen; Ling Chen; Pingming Qiu; Xiuyun Ai; Enping Huang; Weiye Huang; Chuanxiang Chen; Chao Liu; Zhoumeng Lin; Wei-Bing Xie; Huijun Wang
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

6.  Inhibitory effect of melatonin on cerebral endothelial cells dysfunction induced by methamphetamine via NADPH oxidase-2.

Authors:  Pichaya Jumnongprakhon; Piyarat Govitrapong; Chainarong Tocharus; Jiraporn Tocharus
Journal:  Brain Res       Date:  2016-08-30       Impact factor: 3.252

7.  Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss.

Authors:  D C Harvey; G Lacan; S P Tanious; W P Melega
Journal:  Brain Res       Date:  2000-07-21       Impact factor: 3.252

8.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.

Authors:  A J Hotchkiss; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

9.  Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.

Authors:  David M Thomas; Paul D Walker; Joyce A Benjamins; Timothy J Geddes; Donald M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  2004-05-26       Impact factor: 4.030

10.  Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways.

Authors:  Genevieve Beauvais; Kenisha Atwell; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

View more
  15 in total

1.  Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway.

Authors:  Baoyu Shen; Dongxian Zhang; Xiaofeng Zeng; Lina Guan; Genmeng Yang; Liu Liu; Jian Huang; Yuanyuan Li; Shijun Hong; Lihua Li
Journal:  Psychopharmacology (Berl)       Date:  2022-01-08       Impact factor: 4.530

2.  Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration.

Authors:  Aaron E Miller; Atul P Daiwile; Jean Lud Cadet
Journal:  Neurotox Res       Date:  2022-07-14       Impact factor: 3.978

Review 3.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

4.  Behavioral and Brain Reactivity Associated With Drug-Related and Non-Drug-Related Emotional Stimuli in Methamphetamine Addicts.

Authors:  Xiawen Li; Yu Zhou; Guanghui Zhang; Yingzhi Lu; Chenglin Zhou; Hongbiao Wang
Journal:  Front Hum Neurosci       Date:  2022-06-24       Impact factor: 3.473

Review 5.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

6.  Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents.

Authors:  Silja Skogstad Tuv; Marianne Skov-Skov Bergh; Jannike Mørch Andersen; Synne Steinsland; Vigdis Vindenes; Michael H Baumann; Marilyn A Huestis; Inger Lise Bogen
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

7.  Icariside II Attenuates Methamphetamine-Induced Neurotoxicity and Behavioral Impairments via Activating the Keap1-Nrf2 Pathway.

Authors:  Jian Huang; Jiuyang Ding; Zhuo Wang; Yanning Li; Yitong He; Xiaohan Wang; Haoliang Fan; Qiqian Xie; Pingming Qiu
Journal:  Oxid Med Cell Longev       Date:  2022-03-28       Impact factor: 6.543

8.  Neuron-Microglia Contact-Dependent Mechanisms Attenuate Methamphetamine-Induced Microglia Reactivity and Enhance Neuronal Plasticity.

Authors:  Joana Bravo; Inês Ribeiro; Ana Filipa Terceiro; Elva B Andrade; Camila Cabral Portugal; Igor M Lopes; Maria M Azevedo; Mafalda Sousa; Cátia D F Lopes; Andrea C Lobo; Teresa Canedo; João Bettencourt Relvas; Teresa Summavielle
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

9.  Training and transfer effects of working memory updating training in male abstinent long-term methamphetamine users.

Authors:  Xin Zhao; Lei Wang; Joseph H R Maes
Journal:  Addict Behav Rep       Date:  2021-10-08

10.  Quercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and Neuroinflammation.

Authors:  Fengrong Chen; Jiaxue Sun; Cheng Chen; Yongjin Zhang; Lei Zou; Zunyue Zhang; Minghui Chen; Hongjin Wu; Weiwei Tian; Yu Liu; Yu Xu; Huayou Luo; Mei Zhu; Juehua Yu; Qian Wang; Kunhua Wang
Journal:  Front Mol Neurosci       Date:  2022-02-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.